Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities
Net income/Loss	$ (1,056,002)	$ 4,373,199
Adjustments to reconcile net income to net cash (used in) provided by operating activities
Depreciation and amortization	2,865,599	2,261,969
Change in fair value of warrant liability	(528,980)	1,310,026
Non-cash lease expense	1,852,780	2,953,727
Stock-based compensation	5,151,248	534,665
Non-cash interest expense	1,285	0
Change in inventory and receivable reserves	(164,045)	(62,462)
Gain (loss) from equity interests in unconsolidated affiliate	(11,037)	3,173,106
Loss on Drawbridge transaction	0	165,998
Write-off of acquired Drawbridge in-process research and development	0	1,563,015
Other non-cash	(38,628)	0
Change in operating assets and liabilities
Accounts receivable	(5,007,492)	(3,607,072)
Related party receivables	182,605	(618,575)
Related party payables	(759,905)	401,509
Inventories	(19,321,200)	(11,411,154)
Prepaid expenses and other assets	1,515,266	(611,863)
Accounts payable and accrued liabilities	9,923,479	3,704,343
Operating lease liabilities	(1,612,862)	(3,244,257)
Net cash (used in) provided by operating activities	(7,007,889)	886,174
Cash Flows from Investing Activities
Purchase of property and equipment	(2,226,073)	(1,136,975)
Purchase of investment in unconsolidated subsidiaries	(1,000,000)	0
Purchase of license agreements	(375,000)	(563,470)
Net cash used in investing activities	(18,463,360)	(3,112,724)
Cash Flows from Financing Activities
Payments on long-term debt and finance leases	(452,989)	(324,938)
Payment of deferred offering costs	0	(2,990,760)
Debt issuance costs	(25,700)	0
Proceeds from issuance of ownership interest in consolidated subsidiary	2,601,806	0
Proceeds from exercise of stock options	243,943	0
Net cash provided by (used in) financing activities	2,367,060	(3,315,698)
Effect of exchange rate changes on cash and restricted cash	(186,200)	0
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	(23,290,389)	(5,542,248)
Cash and restricted cash, beginning of period	56,000,915	15,262,094
Cash and restricted cash, end of period	32,710,526	9,719,846
Supplemental Disclosure of Cash Flows Information
Cash paid during the year for interest, net of interest received	77,209	371,730
Income tax paid, net of refunds received	573,372	192,618
Noncash Investing and Financing Activities
Equipment acquired through finance lease obligations	52,838	420,361
Equipment acquired through debt obligations	0	1,274,601
Right-of-use assets obtained in exchange for lease liabilities	0	2,913,002
Nutrativa LLC Acquisition [Member]
Cash Flows from Investing Activities
Acquisition, net of cash acquired	14,862,287	0
Drawbridge Health Inc [Member]
Cash Flows from Investing Activities
Acquisition, net of cash acquired	$ 0	$ 1,412,279